| Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome (NCT00556530) | Albert Einstein College of Medicine | 2016-07-01 |
| Expanded Noninvasive Genomic Medical Assessment: The Enigma Study (NCT02787486) | Progenity, Inc. | 2015-10-01 |
| SNP-based Microdeletion and Aneuploidy RegisTry (SMART) (NCT02381457) | Natera, Inc. | 2015-04-01 |
| Immune Disorder HSCT Protocol (NCT01821781) | Washington University School of Medicine | 2013-04-29 |
| Thymus Transplantation Safety-Efficacy (NCT01220531) | Sumitomo Pharma Switzerland GmbH | 2010-12-01 |
| Effects of PTH Replacement on Bone in Hypoparathyroidism (NCT00395538) | National Institute of Dental and Craniofacial Research (NIDCR) | 2006-10-30 |
| Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study (NCT00105274) | National Institute of Mental Health (NIMH) | 2005-03-07 |
| Parathyroid and Thymus Transplantation in DiGeorge #931 (NCT00566488) | Sumitomo Pharma Switzerland GmbH | 2005-01-01 |
| Thymus Transplantation Dose in DiGeorge #932 (NCT00576836) | Sumitomo Pharma Switzerland GmbH | 2004-09-02 |
| Thymus Transplantation With Immunosuppression (NCT00579709) | Sumitomo Pharma Switzerland GmbH | 2002-07-01 |
| Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes (NCT00004351) | National Institute of Neurological Disorders and Stroke (NINDS) | 1999-09-01 |
| Infection in DiGeorge Following CHD Surgery (NCT00278005) | Children's Healthcare of Atlanta | 1998-01-01 |
| Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome (NCT00005102) | National Center for Research Resources (NCRR) | 1995-01-01 |
| Thymus Transplantation in DiGeorge Syndrome #668 (NCT00576407) | Sumitomo Pharma Switzerland GmbH | 1991-10-01 |